APRE Aprea Therapeutics, Inc.

Fundamentals / CIK 0001781983 / USD

Aprea Therapeutics, Inc. reported $38.81M in total assets and a net loss of $14.14M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APRE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$0$0$0-$105.3MFY 2017 Net Income: -$15.19M2017FY 2018 Net Income: -$15.53M2018FY 2019 Net Income: -$28.06M2019FY 2020 Net Income: -$53.48M2020FY 2021 Net Income: -$37.13M2021FY 2022 Net Income: -$112.7M2022FY 2023 Net Income: -$14.29M2023FY 2024 Net Income: -$12.96M2024FY 2025 Net Income: -$12.60M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $7.04M $9.36M $7.63M $16.40M $23.90M $37.88M $20.95M $14.19M $13.39M
Total Operating Expenses $13.52M $15.82M $16.06M $113.4M $37.45M $52.81M $29.54M $16.49M $15.85M
Operating Income -$13.23M -$14.32M -$15.47M -$113.4M -$37.45M -- -- -- --
EBITDA -$13.21M -$14.30M -$15.46M -$113.4M -$37.43M -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$12.60M -$12.96M -$14.29M -$112.7M -$37.13M -$53.48M -$28.06M -$15.53M -$15.19M
Basic EPS -$1.93 -$2.35 -$3.95 -$67.99 -$34.88 -$50.61 -$93.40 -$269.00 -$263.40
Diluted EPS -$1.93 -$2.35 -$3.95 -$67.99 -$34.88 -$50.61 -$93.40 -$269.00 -$263.40
Basic Shares Outstanding 6.5M 5.5M 3.6M 1.7M 1.1M 1.1M 300.1K 57.7K 57.7K
Diluted Shares Outstanding 6.5M 5.5M 3.6M 1.7M 1.1M 1.1M 300.1K 57.7K 57.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.34M $2.46M $1.61M $1.01M $1.64M $1.91M $2.48M $2.36M
Total Operating Expenses $5.17M $4.03M $3.43M $2.65M $3.12M $3.51M $4.25M $3.43M
Operating Income -$5.17M -$4.03M -$3.43M -$2.64M -$3.12M -$3.39M -$4.09M -$3.23M
EBITDA -$5.17M -$4.03M -$3.42M -$2.64M -$3.11M -$3.38M -$4.08M -$3.22M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$4.81M -$3.59M -$3.29M -$2.46M -$2.97M -$3.24M -$3.93M -$2.89M
Basic EPS -$0.09 -$0.07 -$0.22 -- -$0.47 -$0.53 -$0.66 --
Diluted EPS -$0.09 -$0.07 -$0.22 -- -$0.47 -$0.53 -$0.66 --
Basic Shares Outstanding 53.7M 53.5M 14.7M -- 6.4M 6.1M 6.0M --
Diluted Shares Outstanding 53.7M 53.5M 14.7M -- 6.4M 6.1M 6.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $14.60M $22.85M $21.61M $28.79M $53.08M $89.02M $130.1M $65.68M
Cash & Short-Term Investments $14.60M $22.85M $21.61M $28.79M $53.08M $89.02M $130.1M $65.68M
Total Current Assets $15.56M $23.58M $22.52M $30.15M $56.58M $92.42M $133.0M $66.00M
Property, Plant & Equipment, Net $60K $82K $88K $2.3K $24K $39K $42K $24K
Other Non-Current Assets $271K $282K -- -- $29K $29K $107 $111
Total Non-Current Assets $372K $403K $129K $2.3K $239K $389K $563K $25K
Total Assets $15.93M $23.98M $22.65M $30.16M $56.82M $92.81M $133.6M $66.02M
Accounts Payable $714K $1.35M $1.67M $843K $1.77M $4.50M $2.18M $1.74M
Deferred Revenue (Current) -- -- $529K -- -- -- -- --
Total Current Liabilities $2.76M $3.36M $4.39M $3.20M $7.32M $15.33M $9.06M $4.87M
Total Non-Current Liabilities $727K $1.31M $1.31M $0 $0 $79K $303K $0
Total Liabilities $3.49M $4.67M $5.70M $3.20M $7.32M $15.41M $9.36M $4.87M
Total Debt (incl. Leases) -- -- -- -- $190K $335K $545K --
Common Stock $8.2K $5.5K $3.7K $2.7K $1.1K $21K $21K $127K
Retained Earnings -$333.6M -$321.0M -$308.1M -$293.8M -$181.1M -$144.0M -$90.53M -$62.47M
Accumulated Other Comp. Income -$10.63M -$10.63M -$10.61M -$10.62M -$10.36M -$10.04M -$11.53M -$8.76M
Total Stockholders' Equity $12.44M $19.31M $16.95M $25.64M $49.51M $77.40M $124.2M -$51.44M
Total Equity $12.44M $19.31M $16.95M $25.64M $49.51M $77.40M $124.2M -$51.44M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $37.85M $41.23M $46.47M $14.60M $13.72M $16.53M $19.28M $22.85M
Cash & Short-Term Investments $37.85M $41.23M $46.47M $14.60M $13.72M $16.53M $19.28M $22.85M
Total Current Assets $38.44M $41.91M $47.25M $15.56M $13.94M $16.93M $19.83M $23.58M
Property, Plant & Equipment, Net $62K $64K $54K $60K $65K $71K $76K $82K
Other Non-Current Assets $271K $271K $271K $271K $271K $271K $271K $282K
Total Non-Current Assets $375K $377K $367K $372K $377K $382K $388K $403K
Total Assets $38.81M $42.29M $47.61M $15.93M $14.32M $17.31M $20.22M $23.98M
Accounts Payable $1.26M $935K $2.94M $714K $641K $1.20M $1.28M $1.35M
Total Current Liabilities $3.97M $3.09M $5.30M $2.76M $2.68M $3.17M $3.36M $3.36M
Total Non-Current Liabilities $727K $727K $727K $727K $727K $727K $1.31M $1.31M
Total Liabilities $4.70M $3.82M $6.02M $3.49M $3.41M $3.90M $4.67M $4.67M
Common Stock $14K $12K $12K $8.2K $6.0K $5.8K $5.5K $5.5K
Retained Earnings -$345.3M -$340.5M -$336.9M -$333.6M -$331.2M -$328.2M -$325.0M -$321.0M
Accumulated Other Comp. Income -$10.61M -$10.62M -$10.63M -$10.63M -$10.63M -$10.63M -$10.63M -$10.63M
Total Stockholders' Equity $34.11M $38.47M $41.59M $12.44M $10.91M $13.41M $15.55M $19.31M
Total Equity $34.11M $38.47M $41.59M $12.44M $10.91M $13.41M $15.55M $19.31M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.60M -$12.96M -$14.29M -$112.7M -$37.13M -$53.48M -$28.06M -$15.53M -$15.19M
Depreciation & Amortization $22K $22K $7.1K $4.4K $13K $29K $11K $8.3K $7.9K
Stock-Based Compensation -- -- -- -- -- $4.98M $1.35M $330K $395K
Change in Payables -$647K -$314K $827K -$859K -$2.73M $2.33M $438K $214K $327K
Operating Cash Flow -$12.89M -$13.56M -$12.18M -$25.01M -$37.69M -$41.80M -$26.71M -$15.25M -$14.00M
Capital Expenditure -- -$15K -$93K -- -- -$26K -$31K -$3.7K --
Free Cash Flow -- -$13.57M -$12.27M -- -- -$41.83M -$26.74M -$15.25M --
Investing Cash Flow -- -$15K -$93K -- -- -$26K -$31K -$3.7K --
Common Stock Issued $5.05M $16.14M $5.79M $683K $1.54M -- -- -- --
Financing Cash Flow $4.64M $14.82M $5.14M $683K $1.75M $151K $92.58M $56.37M $23.34M
Net Change in Cash -$8.25M $1.25M -$7.13M -$24.33M -$35.94M -$41.68M $65.84M $41.11M $9.34M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.81M -$3.59M -$3.29M -$2.46M -$2.97M -$3.24M -$3.93M -$2.89M
Depreciation & Amortization $5.9K $5.7K $5.4K $5.4K $5.4K $5.4K $5.4K $5.4K
Stock-Based Compensation $100K $100K -- -- $100K $100K $100K --
Change in Payables $323K $190K $33K $69K -$554K -$90K -$72K $202K
Operating Cash Flow -$3.73M -$3.28M -$2.76M -$2.96M -$3.17M -$3.13M -$3.63M -$3.51M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$3.51M
Investing Cash Flow -- -- -- -- -- -- -- $0
Common Stock Issued $0 $500K $35.10M $4.21M $375K $400K $59K $141K
Financing Cash Flow $342K -$1.94M $34.62M $3.84M $358K $385K $56K $134K
Net Change in Cash -- -- $31.87M $880K -$2.81M -$2.75M -$3.58M -$3.38M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -101.3% -67.1% -84.3% -439.3% -75.0% -69.1% -22.6% -- --
Return on Assets (ROA) -79.1% -54.0% -63.1% -373.6% -65.3% -57.6% -21.0% -23.5% --
Current Ratio 5.63x 7.01x 5.14x 9.42x 7.73x 6.03x 14.68x 13.56x --
Quick Ratio 5.28x 6.80x 4.93x 8.99x 7.25x 5.81x 14.36x 13.49x --
Debt to Equity -- -- -- -- 0.00x 0.00x 0.00x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -41.5% -32.0% -28.7% -101.3% -119.5% -103.2% -90.6% -67.1%
Return on Assets (ROA) -36.4% -29.1% -25.1% -79.1% -91.0% -80.0% -69.6% -54.0%
Current Ratio 9.67x 13.55x 8.92x 5.63x 5.20x 5.34x 5.90x 7.01x
Quick Ratio 9.52x 13.33x 8.77x 5.28x 5.12x 5.22x 5.73x 6.80x
Source: SEC EDGAR CompanyFacts (CIK 0001781983) · from December 31, 2017 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal